Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

CPI, LightOx Collaborate on Light Therapy for Skin and Oral Cancers

Facebook Twitter LinkedIn Email Comments
The Center for Process Innovation (CPI) and LightOx Ltd. are collaborating on a photonics project to advance the development of next-generation cancer treatments using phototherapeutic methods.

The project focuses on light-based treatments to target removal of skin and oral cancer cells. CPI is supporting LightOx to develop a range of molecular tools for use in imaging, therapeutics, and assay development. The chemical probes enable cell imaging, detection, tracking, and tagging of bioactive molecules. Tags are imaged using fluorescence and Raman spectroscopy.

Officials said the probes are smaller than any other commercial product available for these applications, bypassing traditional problems associated with fluorescent probes and providing facile delivery into the cell, as well as minimal disruption to cell activity prior to light activation — fundamentally changing the way in which these therapies can be delivered to patients.

The technology also targets therapeutic action to particular body sites using a simple delivery system that enables instant treatment, as well as cell death of selected cells and tissues without damage to healthy cells, minimizing side effects for patients.

The collaboration forms part of the Spotlight program, a partnership between CPI and Durham University that is funded by the European Regional Development Fund (ERDF). Providing support to small to medium enterprises in the County Durham area, Spotlight helps businesses perform early stage proof-of-concept research and supports the scaling of photonics technologies to accelerate commercialization into the health care sector.

CPI’s health care photonics team has supported the progression of LightOx’s molecular technology through optical analysis of LightOx’s fluorescent drugs. Complementing this analysis, Durham University helped produce a prototype controllable, calibrated, light-delivery system to allow LightOx to validate new compounds. LightOx is in the process of developing its products for clinical applications.

The project comes shortly after the opening of CPI’s new National Healthcare Photonics Centre. The center will support the creation of medtech products by acting as a hub for partnerships between businesses and academic teams to work on new diagnosis methods, imaging systems (including endoscopy), and light-based treatments.

BioPhotonics
Jul/Aug 2019
GLOSSARY
raman spectroscopy
That branch of spectroscopy concerned with Raman spectra and used to provide a means of studying pure rotational, pure vibrational and rotation-vibration energy changes in the ground level of molecules. Raman spectroscopy is dependent on the collision of incident light quanta with the molecule, inducing the molecule to undergo the change.
fluorescence
The emission of light or other electromagnetic radiation of longer wavelengths by a substance as a result of the absorption of some other radiation of shorter wavelengths, provided the emission continues only as long as the stimulus producing it is maintained. In other words, fluorescence is the luminescence that persists for less than about 10-8 s after excitation.
Research & TechnologyEuropeeducationLightOxCenter for Process InnovationRaman spectroscopyfluorescencedurham universitycancerBiophotonicslight sourcesRapidScan

Comments
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.